HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Snoring

Rough, noisy breathing during sleep, due to vibration of the uvula and soft palate.
Also Known As:
Snorings
Networked: 1400 relevant articles (152 outcomes, 162 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Apnea
2. Obstructive Sleep Apnea
3. Disorders of Excessive Somnolence (Hypersomnia)
4. Nasal Obstruction
5. Mouth Breathing

Experts

1. Gozal, David: 24 articles (01/2020 - 03/2003)
2. Li, Hsueh-Yu: 15 articles (01/2022 - 06/2006)
3. Kaditis, Athanasios G: 13 articles (10/2018 - 06/2004)
4. Kheirandish-Gozal, Leila: 12 articles (01/2020 - 04/2007)
5. Gourgoulianis, Konstantinos: 12 articles (10/2018 - 06/2004)
6. Franklin, Karl A: 11 articles (01/2022 - 04/2004)
7. Lee, Li-Ang: 11 articles (01/2022 - 02/2008)
8. Chen, Ning-Hung: 10 articles (01/2019 - 06/2006)
9. Alexopoulos, Emmanouel I: 10 articles (06/2014 - 06/2004)
10. Lin, Hsin-Ching: 8 articles (10/2021 - 10/2007)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Snoring:
1. Oxygen (Dioxygen)IBA
2. SteroidsIBA
3. Mometasone Furoate (Nasonex)FDA LinkGeneric
4. nasIBA
5. LipidsIBA
6. Budesonide (Pulmicort)FDA LinkGeneric
7. Nasal Decongestants (Decongestants)IBA
8. agomelatine (S20098)IBA
9. Polyethylene Terephthalates (Polyethylene Terephthalate)IBA
10. salicylhydroxamic acid (SHAM)IBA
01/01/2023 - "SOS, SBPS and VAS snoring scores improved in the NightLase group (33.7 ± 14.1 to 56.2 ± 16.1) (35.0 ± 17.1 to 61.5 ± 16.4) and (7.9 ± 2.0 to 4.7 ± 2.8) while no changing in the sham group (32.2 ± 14.5 vs 32.1 ± 13.0) (36.7 ± 12.1 vs 34.7 ± 12.7) (8.1 ± 1.7 vs 8.0 ± 1.6), respectively. "
10/09/2019 - "While observed adherence varied between countries, adherence during sham screening, initial titration, and the first month of treatment retained independent predictive value in the multivariate model along with fixed CPAP pressure and very loud snoring. "
01/01/2018 - "Mean snoring time per night was shorter with the Active MAS than with the Sham MAS (-46.3 min; 95% CI = 14.5-78.1; p = 0.004). "
01/01/2009 - "Randomized controlled trials of surgery vs. sham surgery or conservative treatment in adults, with daytime sleepiness, quality of life, apnea-hypopnea index, and snoring as outcomes were included. "
11/03/2020 - "In adults, compared to sham therapy, myofunctional therapy: probably reduces daytime sleepiness (Epworth Sleepiness Scale (ESS), MD (mean difference) -4.52 points, 95% Confidence Interval (CI) -6.67 to -2.36; two studies, 82 participants; moderate-certainty evidence); may increase sleep quality (MD -3.90 points, 95% CI -6.31 to -1.49; one study, 31 participants; low-certainty evidence); may result in a large reduction in Apnoea-Hypopnoea Index (AHI, MD -13.20 points, 95% CI -18.48 to -7.93; two studies, 82 participants; low-certainty evidence); may have little to no effect in reduction of snoring frequency but the evidence is very uncertain (Standardised Mean Difference (SMD) -0.53 points, 95% CI -1.03 to -0.03; two studies, 67 participants; very low-certainty evidence); and probably reduces subjective snoring intensity slightly (MD -1.9 points, 95% CI -3.69 to -0.11 one study, 51 participants; moderate-certainty evidence). "

Therapies and Procedures

1. Therapeutics
2. Nasal Surgical Procedures
3. Lasers (Laser)
4. Continuous Positive Airway Pressure
04/01/2002 - "The guideline contains the following recommendations for the diagnosis of OSAS: 1) all children should be screened for snoring; 2) complex high-risk patients should be referred to a specialist; 3) patients with cardiorespiratory failure cannot await elective evaluation; 4) diagnostic evaluation is useful in discriminating between primary snoring and OSAS, the gold standard being polysomnography; 5) adenotonsillectomy is the first line of treatment for most children, and continuous positive airway pressure is an option for those who are not candidates for surgery or do not respond to surgery; 6) high-risk patients should be monitored as inpatients postoperatively; 7) patients should be reevaluated postoperatively to determine whether additional treatment is required. "
05/15/2017 - "The Efficacy of Low-Level Continuous Positive Airway Pressure for the Treatment of Snoring."
05/01/2007 - "Continuous positive airway pressure improved sleep quality, although some symptoms, mainly snoring, persisted. "
11/01/2015 - "Although nasal pressure recordings provide information regarding nocturnal breathing abnormalities in a polysomnography (PSG) study or continuous positive airway pressure (CPAP) system, an objective assessment of snoring detection using these nasal pressure recordings has not yet been reported in the literature. "
01/01/2002 - "A bench study using an artificial lung model was performed to evaluate the snoring detection sensitivity of six (commercially available) auto-nasal continuous positive airway pressure (NCPAP) devices. "
5. Occlusal Splints